• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化与慢性过敏性肺炎的生存分析比较。

Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

机构信息

Interstitial lung disease clinic. Hospital María Ferrer Buenos Aires, Argentina.

Interstitial lung disease clinic. Hospital María Ferrer Buenos Aires, Argentina.

出版信息

Pulmonology. 2020 Jan-Feb;26(1):3-9. doi: 10.1016/j.pulmoe.2019.08.007. Epub 2019 Nov 14.

DOI:10.1016/j.pulmoe.2019.08.007
PMID:31735689
Abstract

INTRODUCTION

Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential diagnosis. The aim of our study is to compare survival and functional decline between these two entities.

METHODS

Survival and functional decline more than 10% in FVC were compared using Kaplan Meier (KM) method between patients with CHP and IPF. Cox proportional hazard analysis was used to identify independent predictors of survival and functional decline.

RESULTS

146 patients were included, 54 with CHP and 92 with IPF. KM rate for 2 years survival was 0.71 (CI 95% 0,6-0,8) for CHP group and 0,83 (CI 95% 0,66 - 0,92) for IPF (p=0,027). Nevertheless this difference disappeared using Cox proportional hazard analysis, the adjusted HR for survival among CHP patients was 0,53 (CI 95% 0,25-1,15) (p=0,11). There was no difference in functional evolution between the two groups. KM rate for a decline more than or equal to 10% was 0,64 for CHP (CI 95% 0,43-0,79) and 0,78 for IPF (IC 95% 0,6-0,88) (p=0,22). This observation did not change after using Cox proportional hazard analysis.

CONCLUSIONS

Our study shows that both IPF and CHP are fibrosing interstitial diseases with a similar evolution and survival. It might be possible that therapeutic approach in patients with CHP should change in the light of these observations.

摘要

简介

慢性过敏性肺炎(CHP)是一种间质性肺疾病,治疗反应有限,预后不良。有时它与特发性肺纤维化(IPF)无法区分,成为主要鉴别诊断之一。我们研究的目的是比较这两种疾病的生存和功能下降情况。

方法

使用 Kaplan-Meier(KM)方法比较 CHP 和 IPF 患者的生存和 FVC 下降超过 10%的情况。使用 Cox 比例风险分析确定生存和功能下降的独立预测因素。

结果

共纳入 146 例患者,其中 CHP 54 例,IPF92 例。CHP 组 2 年生存率为 0.71(95%CI 0.6-0.8),IPF 组为 0.83(95%CI 0.66-0.92)(p=0.027)。然而,使用 Cox 比例风险分析后,这种差异消失了,CHP 患者的生存调整 HR 为 0.53(95%CI 0.25-1.15)(p=0.11)。两组患者的功能变化无差异。CHP 组下降超过或等于 10%的 KM 率为 0.64(95%CI 0.43-0.79),IPF 组为 0.78(95%CI 0.6-0.88)(p=0.22)。使用 Cox 比例风险分析后,这一观察结果没有改变。

结论

我们的研究表明,IPF 和 CHP 都是纤维化的间质性疾病,具有相似的演变和生存。根据这些观察结果,CHP 患者的治疗方法可能需要改变。

相似文献

1
Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.特发性肺纤维化与慢性过敏性肺炎的生存分析比较。
Pulmonology. 2020 Jan-Feb;26(1):3-9. doi: 10.1016/j.pulmoe.2019.08.007. Epub 2019 Nov 14.
2
Clinical behaviour of patients exposed to organic dust and diagnosed with idiopathic pulmonary fibrosis.接触有机粉尘并被诊断为特发性肺纤维化的患者的临床行为。
Respirology. 2018 Dec;23(12):1160-1165. doi: 10.1111/resp.13342. Epub 2018 Jun 13.
3
Pathology of Chronic Hypersensitivity Pneumonitis What Is It? What Are the Diagnostic Criteria? Why Do We Care?慢性过敏性肺炎的病理学 它是什么?诊断标准是什么?我们为何关注?
Arch Pathol Lab Med. 2018 Jan;142(1):109-119. doi: 10.5858/arpa.2017-0173-RA. Epub 2017 May 24.
4
Chronic hypersensitivity pneumonitis: identification of key prognostic determinants using automated CT analysis.慢性过敏性肺炎:使用自动CT分析确定关键预后决定因素
BMC Pulm Med. 2017 May 4;17(1):81. doi: 10.1186/s12890-017-0418-2.
5
High-resolution CT features distinguishing usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis from those with idiopathic pulmonary fibrosis.高分辨率CT特征鉴别慢性过敏性肺炎中的寻常型间质性肺炎模式与特发性肺纤维化中的模式。
Jpn J Radiol. 2020 Jun;38(6):524-532. doi: 10.1007/s11604-020-00932-6. Epub 2020 Feb 26.
6
Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory.过敏性肺炎:影像学表型与不同的生存时间和肺功能轨迹相关。
Chest. 2019 Apr;155(4):699-711. doi: 10.1016/j.chest.2018.08.1076. Epub 2018 Sep 19.
7
Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.间质性肺疾病的住院率:对肺纤维化基金会登记处的分析。
Am J Respir Crit Care Med. 2024 Sep 15;210(6):801-813. doi: 10.1164/rccm.202309-1708OC.
8
Chronic hypersensitivity pneumonitis or idiopathic pulmonary fibrosis? Diagnostic role of high resolution Computed Tomography (HRCT).慢性过敏性肺炎还是特发性肺纤维化?高分辨率计算机断层扫描(HRCT)的诊断作用。
Radiol Med. 2003 Sep;106(3):135-46.
9
Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study.特发性肺纤维化患者的慢性过敏性肺炎:一项前瞻性病例队列研究。
Lancet Respir Med. 2013 Nov;1(9):685-94. doi: 10.1016/S2213-2600(13)70191-7. Epub 2013 Oct 21.
10
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures.慢性过敏性肺炎,一种具有独特分子特征的间质性肺疾病。
Am J Respir Crit Care Med. 2020 Nov 15;202(10):1430-1444. doi: 10.1164/rccm.202001-0134OC.

引用本文的文献

1
Advance Care Planning: A Retrospective Audit in a National Referral Center for Interstitial Lung Diseases.预先护理计划:在一家全国间质性肺疾病转诊中心的回顾性审计
Am J Hosp Palliat Care. 2025 Apr;42(4):372-381. doi: 10.1177/10499091241267914. Epub 2024 Oct 14.
2
Hypersensitivity Pneumonitis: An Interesting Case of Acute Shortness of Breath in a Young Patient.过敏性肺炎:一名年轻患者急性气短的有趣病例。
Cureus. 2024 Sep 5;16(9):e68683. doi: 10.7759/cureus.68683. eCollection 2024 Sep.
3
BAL Fluid Cellular Analysis and Radiologic Patterns in Patients With Fibrotic Interstitial Lung Disease.
纤维化间质性肺疾病患者的支气管肺泡灌洗(BAL)液细胞分析及放射学模式
Chest. 2025 Jan;167(1):172-182. doi: 10.1016/j.chest.2024.07.166. Epub 2024 Aug 22.
4
Survival and Lung Function Changes in Hypersensitivity Pneumonitis According to Radiological Phenotypes Compared With Idiopathic Pulmonary Fibrosis.与特发性肺纤维化相比,根据放射学表型分析的过敏性肺炎的生存情况和肺功能变化
Cureus. 2024 Mar 31;16(3):e57307. doi: 10.7759/cureus.57307. eCollection 2024 Mar.
5
Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis.纤维化评分可预测纤维化性过敏性肺炎患者的死亡率。
Front Med (Lausanne). 2023 Mar 21;10:1131070. doi: 10.3389/fmed.2023.1131070. eCollection 2023.
6
Decreased Survival and Lung Function in Progressive Pulmonary Fibrosis.进行性肺纤维化的生存率和肺功能下降。
Medicina (Kaunas). 2023 Feb 5;59(2):296. doi: 10.3390/medicina59020296.
7
Predictors of Progression and Mortality in Patients with Chronic Hypersensitivity Pneumonitis: Retrospective Analysis of Registry of Fibrosing Interstitial Lung Diseases.慢性过敏性肺炎患者病情进展和死亡率的预测因素:间质性肺疾病纤维化登记处的回顾性分析
Life (Basel). 2023 Feb 8;13(2):467. doi: 10.3390/life13020467.
8
Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia.东西伯利亚间质性肺疾病前瞻性登记中的肺纤维化和进行性肺纤维化
Life (Basel). 2023 Jan 11;13(1):212. doi: 10.3390/life13010212.
9
Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches.纤维化性过敏性肺炎的诊断与管理挑战:当前方法的实用综述
J Clin Med. 2022 Mar 8;11(6):1473. doi: 10.3390/jcm11061473.
10
Diagnosis, course and management of hypersensitivity pneumonitis.过敏性肺炎的诊断、病程和管理。
Eur Respir Rev. 2022 Feb 9;31(163). doi: 10.1183/16000617.0169-2021. Print 2022 Mar 31.